| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Repare Therapeutics Inc. | EVP, CHIEF FINANCIAL OFFICER | Common Shares | 54,786 | $62,456 | $1.14 | 12 Mar 2025 | Direct |
| Repare Therapeutics Inc. | EVP, CHIEF FINANCIAL OFFICER | Employee Stock Option (right to buy) | 500,000 | 02 Apr 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| RPTX | Repare Therapeutics Inc. | 02 Apr 2025 | 1 | $0 | 4 | EVP, CHIEF FINANCIAL OFFICER | 04 Apr 2025, 16:15 |
| RPTX | Repare Therapeutics Inc. | 12 Mar 2025 | 1 | -$7,848 | 4 | EVP, CHIEF FINANCIAL OFFICER | 14 Mar 2025, 16:30 |
| RPTX | Repare Therapeutics Inc. | 04 Mar 2025 | 3 | $0 | 4 | EVP, CHIEF FINANCIAL OFFICER | 06 Mar 2025, 17:00 |
| RPTX | Repare Therapeutics Inc. | 28 Mar 2024 | 2 | -$7,449 | 4 | EVP, CHIEF FINANCIAL OFFICER | 01 Apr 2024, 21:30 |
| RPTX | Repare Therapeutics Inc. | 25 Mar 2024 | 3 | -$11,558 | 4 | EVP, CHIEF FINANCIAL OFFICER | 27 Mar 2024, 18:59 |
| RPTX | Repare Therapeutics Inc. | 01 Mar 2024 | 2 | $0 | 4 | EVP, CHIEF FINANCIAL OFFICER | 05 Mar 2024, 16:15 |
| RPTX | Repare Therapeutics Inc. | 30 Jan 2023 | 2 | $0 | 4 | EVP, Chief Financial Officer | 01 Feb 2023, 20:44 |
| RPTX | Repare Therapeutics Inc. | 18 Jan 2022 | 1 | $0 | 4 | EVP, Chief Financial Officer | 20 Jan 2022, 15:45 |